Durability of Effect With Long-Term Droxidopa Treatment in Patients with Symptomatic Neurogenic Orthostatic Hypotension

被引：0
|
作者：
Isaacson, Stuart [3 ]
Lisk, Jerome [4 ]
Liang, Grace [2 ]
Rowse, Gerald [1 ]
机构：
[1] Lundbeck NA Ltd, Charlotte, NC USA
[2] Neurocrine Biosci Inc, San Diego, CA USA
[3] Parkinsons Dis & Movement Disorders Ctr Boca Rato, Boca Raton, FL USA
[4] Southern Calif Movement Disorder Specialists, Pasadena, CA USA
来源：
NEUROLOGY | 2016年 / 86卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P5.128
引用
收藏
页数：2
相关论文
共 50 条
  • [21] A multicenter, open-label study to assess the long-term safety of droxidopa in patients with symptomatic neurogenic orthostatic hypotension (NOH 304)
    Shill, H.
    Vernino, S.
    Hutchman, R.
    Adkins, L.
    Isaacson, S.
    MOVEMENT DISORDERS, 2012, 27 : S428 - S428
  • [22] Droxidopa: A Review of Its Use in Symptomatic Neurogenic Orthostatic Hypotension
    Gillian M. Keating
    Drugs, 2015, 75 : 197 - 206
  • [23] Randomized Withdrawal Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension Responsive to Droxidopa
    Biaggioni, Italo
    Freeman, Roy
    Mathias, Christopher J.
    Low, Phillip
    Hewitt, L. Arthur
    Kaufmann, Horacio
    HYPERTENSION, 2015, 65 (01) : 101 - +
  • [24] Unit Droxidopa - a Treatment Option for neurogenic orthostatic Hypotension?
    Schuberth, Madeleine
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2014, 82 (12) : 676 - 676
  • [25] Impact of droxidopa treatment in patients with Parkinson's disease and symptomatic neurogenic orthostatic hypotension (study 306)
    Isaacson, S. H.
    Hauser, R. A.
    Szakacs, C. B. N.
    Cioffi, C. C.
    MOVEMENT DISORDERS, 2013, 28 : S167 - S167
  • [26] Droxidopa for the treatment of neurogenic orthostatic hypotension in neurodegenerative diseases
    Perez-Lloret, Santiago
    Quarracino, Cecilia
    Otero-Losada, Matilde
    Rascol, Olivier
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (06) : 635 - 645
  • [27] Analysis of Droxidopa for the Treatment of Neurogenic Orthostatic Hypotension in Patients with Parkinson Disease
    Hewitt, L. Arthur
    Ziemann, Adam
    Biaggioni, Italo
    Cherny, Katya
    Vernino, Steven
    NEUROLOGY, 2017, 88
  • [28] Effect of the Initial Maintenance Dose of Droxidopa on Treatment Persistence in Patients With Neurogenic Orthostatic Hypotension
    Hewitt, L. Arthur
    Amjad, Fahd
    Kymes, Steven
    Polenchar, Brett
    Favit, Antonella
    NEUROLOGY, 2021, 96 (15)
  • [29] Real-world droxidopa or midodrine treatment persistence in patients with neurogenic orthostatic hypotension or orthostatic hypotension
    Kymes, Steven M.
    Sullivan, Christine
    Jackson, Kenneth
    Raj, Satish R.
    AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL, 2020, 225
  • [30] Analysis of Droxidopa for the Treatment of Neurogenic Orthostatic Hypotension in Patients with Parkinson Disease
    Hewitt, L. A.
    Biaggioni, I.
    Ziemann, A.
    Vernino, S.
    MOVEMENT DISORDERS, 2017, 32 (09) : E8 - E8
12345